Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.

Elbadawi, Ayman; Mahtta, Dhruv; Elgendy, Islam Y; Saad, Marwan; Krittanawong, Chayakrit; Hira, Ravi S; Omer, Mohamed; Ogunbayo, Gbolahan O; Garratt, Kirk; Rao, Sunil V; Jneid, Hani

Elbadawi, Ayman; Mahtta, Dhruv; Elgendy, Islam Y; Saad, Marwan; Krittanawong, Chayakrit; Hira, Ravi S; Omer, Mohamed; Ogunbayo, Gbolahan O; Garratt, Kirk; Rao, Sunil V; Jneid, Hani.

JACC Cardiovasc Interv ; 13(19): 2312-2314, 2020 10 12.

Article in English | MEDLINE | ID: covidwho-813669

Subject(s)

Betacoronavirus; Coronavirus Infections/epidemiology; Fibrinolytic Agents/therapeutic use; Pandemics; Pneumonia, Viral/epidemiology; ST Elevation Myocardial Infarction/drug therapy; Thrombolytic Therapy/trends; Aged; COVID-19; Comorbidity; Female; Humans; Male; Middle Aged; SARS-CoV-2; ST Elevation Myocardial Infarction/epidemiology; Thrombolytic Therapy/methods; Treatment Outcome; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thrombolytic Therapy / Coronavirus Infections / Pandemics / Fibrinolytic Agents / ST Elevation Myocardial Infarction / Betacoronavirus Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JACC Cardiovasc Interv Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google